Skip to main content
Price comparison onlyNot medical adviceUsing this site means you accept our Terms & PrivacyAlways confirm with your pharmacist

Compounded tirzepatide

Compounded tirzepatide is available online through BetterBuyRx as of August 2026, with published pricing from $299. An online visit comes first, a licensed provider reviews it, and treatment proceeds only if the provider decides it is appropriate for you.

The FDA label excerpts below describe the branded tirzepatide product. The program dispenses compounded tirzepatide, which is not the branded product and is not FDA-approved.

Provider approval required. A licensed provider reviews every request and prescribes only when clinically appropriate, we never sell prescription medication directly.

Compounded medications are not FDA-approved

Compounded medications, including compounded semaglutide and compounded tirzepatide, are not FDA-approved as compounded products. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. A licensed provider will determine whether a compounded or brand-name medication is appropriate for you.

Published pricing

What Compounded tirzepatide costs here

Every treatment has one published price, and the price you see is the price you are charged at booking.

Compounded tirzepatide published prices
TreatmentPublished price
Tirzepatide · 5 mg$299/mo
Tirzepatide · 7.5 mg$299/mo
Tirzepatide · 10 mg+$299/mo
Oral tirzepatide$299/mo
What the price covers
You pay
$299/mo

Covers the provider visit and your medication for the period, prescribed only if a licensed provider decides it is appropriate for you.

The price you see here is the price at booking. No membership fee is required, and a free call with the care team is always available first if you want help choosing.

  • Tirzepatide · 5 mg: Dual-agonist starting dose.
  • Tirzepatide · 7.5 mg: The mid-step tirzepatide tier.
  • Tirzepatide · 10 mg+: Higher-dose maintenance tier.
  • Oral tirzepatide: Tirzepatide without the injection.

From the FDA label

What the FDA-approved label says

These excerpts come from the FDA-approved product labels for the underlying medicines. They describe the approved products, not the compounded preparation dispensed through this program.

MOUNJARO (tirzepatide) · indications and usage
INDICATIONS AND USAGE MOUNJARO ® is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. MOUNJARO ® is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. ( 1 )

Source: FDA label for MOUNJARO via DailyMed · openFDA, accessed 2026-08-31.

Results vary. Clinical trial results apply only to the FDA-approved branded medication specifically identified and do not apply to compounded medications. All medications must be prescribed by a licensed provider based on medical necessity.

Safety

Safety information from the FDA label

Short excerpts only. Read the full current label and discuss your health history with your provider before starting treatment.

MOUNJARO (tirzepatide) · warnings
Boxed warning: WARNING: RISK OF THYROID C-CELL TUMORS In both male and female rats, tirzepatide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures. [...] WARNINGS AND PRECAUTIONS Acute Pancreatitis: Has been observed in patients treated with GLP-1 receptor agonists, or MOUNJARO. Discontinue if pancreatitis is suspected. ( 5.2 ) Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin: Concomitant use with an insulin secretagogue or insulin may increase the risk of hypoglycemia, including severe hypoglycemia. Reducing dose of insulin secretagogue or insulin may be necessary. [...]

Source: FDA label for MOUNJARO via DailyMed · openFDA, accessed 2026-08-31.

Questions

Compounded tirzepatide, answered

What does Compounded tirzepatide cost at BetterBuyRx?
Published pricing starts at $299. Every treatment has one published price, and the price you see is the price you are charged at booking.
Who decides whether Compounded tirzepatide is right for me?
Provider approval required. A licensed provider reviews every request and prescribes only when clinically appropriate, we never sell prescription medication directly.
Is the compounded preparation the same as a branded product?
No. Compounded medications, including compounded semaglutide and compounded tirzepatide, are not FDA-approved as compounded products. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. A licensed provider will determine whether a compounded or brand-name medication is appropriate for you.
Where can I read the full prescribing information?
The complete FDA label is published on DailyMed. The excerpts on this page were accessed 2026-08-31; always review the full current label with your provider.

More options in this category: Weight loss

Start with the Weight loss program

The program page covers the online visit, the provider review, and exactly what the published price includes. A free call with the care team is available before you book anything.

Go to the Weight loss program